Reported about 17 hours ago
Oppenheimer's chief investment strategist expresses optimism about the stock market's trajectory, projecting significant gains for two specific stocks: Rani Therapeutics, which innovates oral delivery of biologics, and Ultra Clean Holdings, which supports the semiconductor industry. With favorable analyst ratings, Rani is expected to reach a price target of $17 (up 740% potential) and Ultra Clean a target of $70 (76% potential). Both companies are seen as positioning themselves well in booming markets.
Source: YAHOO